poisar

Stocks · News reference

One of Israel Englander's Biotech Picks Just Turned Into a $500M Merger Story

BenzingaAug 21, 2026, 1:30 PMSurbhi Jain

Werewolf Therapeutics surged after announcing a $500 million merger with Ambros Therapeutics, putting focus on Israel Englander's holding.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Aug 21, 2026, 1:30 PM
Checked
Aug 21, 2026, 1:30 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading